Lundbeck Is Said to Express Interest in Buying Xeris Biopharma

H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma Holdings Inc., a commercial-stage drugmaker, according to people familiar with the matter. The potential deal signals consolidation in the pharmaceutical sector as Lundbeck seeks to expand its portfolio. No financial terms were disclosed, and discussions are reportedly ongoing.